Your browser doesn't support javascript.
loading
SSRI withdrawal syndrome in children and adolescents: a narrative literature review.
Khan, Yasser Saeed; Khoodoruth, Mohamed Adil Shah; Albobali, Yahia; Haddad, Peter M.
Afiliação
  • Khan YS; Child and Adolescent Mental Health Service, Hamad Medical Corporation, Doha, Qatar.
  • Khoodoruth MAS; Child and Adolescent Mental Health Service, Hamad Medical Corporation, Doha, Qatar.
  • Albobali Y; Division of Genomics and Precision Medicine, College of Health and Life Sciences, Hamad Bin Khalifa University, Education City, Doha, Qatar.
  • Haddad PM; Child and Adolescent Mental Health Service, Hamad Medical Corporation, Doha, Qatar.
Expert Opin Drug Saf ; 22(5): 381-390, 2023.
Article em En | MEDLINE | ID: mdl-37339264
INTRODUCTION: While there is considerable published evidence regarding the nature and severity of Selective Serotonin Reuptake Inhibitor (SSRI) discontinuation symptoms in the adult population, information relating to the child and adolescent population remains scarce. This narrative review examined the published literature on SSRI withdrawal symptoms in the under-18-year-old age group. MEDLINE and PsycINFO were comprehensively searched from inception to 5 May 2023. AREAS COVERED: This review highlights the importance of recognizing SSRI withdrawal in children and adolescents and summarizes available literature and guidelines for safe discontinuation. EXPERT OPINION: Evidence of the presence of SSRI withdrawal phenomenon in children and adolescents mainly originates from case reports and extrapolated adult data. Existing data on SSRI withdrawal syndrome in children and adolescents is therefore limited, and there is a need for formal research in this specific population to establish with more certainty the nature and extent of SSRI withdrawal syndrome. Nevertheless, there is currently enough evidence available for prescribing clinicians to provide psychoeducation to patients and families about the possibility of withdrawal symptoms when SSRI treatment is considered. The need for gradual and planned discontinuation should also be discussed for safe withdrawal.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Inibidores Seletivos de Recaptação de Serotonina Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Inibidores Seletivos de Recaptação de Serotonina Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2023 Tipo de documento: Article